Savella Fibromyalgia Treatment
Learn All About The Savella Fibromyalgia Treatment.
Savella is a drug licensed from Pierre Fabre and Cypress Bioscience, Inc. to Forest Laboratories, Inc. under the heading of Forest Pharmaceuticals, Inc. Based out of New York City, this company puts forth a billion dollars in research and development of new drugs. Further, they are on the forefront of getting European pharmaceuticals licensed for sale in the USA. Some of their other products include Lexapro for depression and Nemanda for the treatment of Alzheimer’s Disease.
The reason that people need Savella fibromyalgia treatment is because the safety of Savella fibromyalgia treatment was established in two pivotal phase III clinical trials involving more than 2,000 patients. When people employed Savella fibromyalgia treatment, patients not only found that their pain management was increased, they also gained in their physical function and global assessment. This selective serotonin and norepinephrine dual reuptake inhibitor (known generically as milnacipran HCl) cuts through the cognitive difficulties experienced by many fibromyalgia sufferers and gives them back a piece of their life.
Forest Laboratories currently does not have any other fibromyalgia treatments. Instead, they have focused their time, resources, and clinical energies on Savella fibromyalgia treatment.
What makes Savella fibromyalgia treatment so important for people suffering from fibromyalgia is that this product has been certified by the FDA.
There are a lot of homeopathic remedies, vitamin supplements, and other treatments available in stores and online. However, despite their claims of aid, these claims have not been tested. The FDA has tested Savella fibromyalgia treatment and has released it to be sold to the American public.
Further, Savella is the first drug to be approved to treat fibromyalgia with a composite responder analysis. Although many fibromyalgia drugs seek to treat only one aspect of the disease, Savella fibromyalgia treatment has been tested to affect pain, global assessment, and physical function at all dosage levels.